Battling bullies and other tales by Vertex's new CEO

Matthew Emmens hates golf. For more on the new CEO of Vertex Pharmaceuticals--and ex-chief of Shire--see the Boston Business Journal profile. One tidbit: He's written an allegorical business tale whose moral is, essentially, tell truth to power. He promises to listen at Vertex. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.